Exelixis Goodwill

Exelixis (EXEL) currently reports a goodwill of $64M as of July 2026. That compares with $64M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Exelixis's goodwill history and peer comparisons.

Exelixis's goodwill was unchanged from $64M to $64M — essentially flat versus a year earlier (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Exelixis reported $64M in goodwill as of July 2026. That compares with $64M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $64M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Exelixis, and consider following EXEL for alerts when major investors trade the stock.

Exelixis is classified in the Healthcare sector. On goodwill, it currently shows $64M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EXEL with unrelated industries.